Safety and Efficacy of 6-thioguanine as a Second-line Treatment for Autoimmune Hepatitis

被引:21
|
作者
Legue, Clemence [1 ]
Legros, Ludivine [1 ]
Kammerer-Jacquet, Solene [2 ,3 ]
Jezequel, Caroline [1 ]
Houssel-Debry, Pauline [1 ]
Uguen, Thomas [1 ]
Le Lan, Caroline [1 ]
Guillygomarc'h, Anne [1 ]
Moirand, Romain [1 ,3 ]
Turlin, Bruno [2 ]
Guyader, Dominique [1 ,3 ]
Bardou-Jacquet, Edouard [1 ,3 ,4 ]
机构
[1] CHU Rennes, Dept Hepatol, Rennes, France
[2] CHU Rennes, Dept Anatomopathol, Rennes, France
[3] Univ Rennes 1, Fac Med, Rennes, France
[4] INSERM, CIC 1414, Rennes, France
关键词
MYCOPHENOLATE-MOFETIL; PREVALENCE; THERAPY;
D O I
10.1016/j.cgh.2017.07.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:290 / 291
页数:2
相关论文
共 50 条
  • [1] Evaluation of 6-thioguanine therapy in autoimmune hepatitis
    van den Brand, F. F.
    de Boer, Y. S.
    Verwer, B. J.
    Bloemena, E.
    de Boer, N.
    Mulder, C. J.
    van Nieuwkerk, C. M.
    Bouma, G.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S353 - S354
  • [2] Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis
    Peiseler, Moritz
    Liebscher, Tina
    Sebode, Marcial
    Zenouzi, Roman
    Hartl, Johannes
    Ehlken, Hanno
    Pannicke, Nadine
    Weiler-Normann, Christina
    Lohse, Ansgar W.
    Schramm, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (02) : 260 - +
  • [3] Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance
    Huebener, Sina
    Oo, Ye Htun
    Than, Nwe Ni
    Huebener, Peter
    Weiler-Normann, Christina
    Lohse, Ansgar W.
    Schramm, Christoph
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (03) : 445 - 453
  • [4] Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine
    de Boer, NKH
    van Nieuwkerk, CMJ
    Pages, MNA
    de Boer, SY
    Derijks, LJJ
    Mulder, CJJ
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (04) : 457 - 461
  • [5] Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis
    Efe, Cumali
    Hagstrom, Hannes
    Ytting, Henriette
    Bhanji, Rahima A.
    Muller, Niklas F.
    Wang, Qixia
    Purnak, Tugrul
    Muratori, Luigi
    Werner, Marten
    Marschall, Hanns-Ulrich
    Muratori, Paolo
    Gunsar, Fulya
    Klintman, Daniel
    Pares, Albert
    Heurgue-Berlot, Alexandra
    Schiano, Thomas D.
    Cengiz, Mustafa
    Tana, Michele May-Sien
    Ma, Xiong
    Montano-Loza, Aldo J.
    Berg, Thomas
    Verma, Sumita
    Larsen, Fin Stolze
    Ozaslan, Ersan
    Heneghan, Michael A.
    Yoshida, Eric M.
    Wahlin, Staffan
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (12) : 1950 - +
  • [6] Second-line immunosuppressants for autoimmune hepatitis
    Efe, Cumali
    Ozaslan, Ersan
    Purnak, Tugrul
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (04) : 490 - 491
  • [7] Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease
    Qasim, Asghar
    McDonald, Sharon
    Sebastian, Shaji
    Mcloughlin, Ramona
    Buckley, Martin
    O'Connor, Humphrey
    O'Morain, Colm
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (02) : 194 - 199
  • [8] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [9] Second-Line Treatment of Autoimmune Hepatitis: Mycophenolate Mofetil as an effective Treatment Option?
    Ploch, P.
    Marquardt, J.
    Fritsche, S.
    Krupp, M.
    Galle, P.
    Teufel, A.
    Barreiros, A.
    INTERNIST, 2013, 54 : 26 - 26
  • [10] TREATMENT OF NEPHROSIS WITH 6-THIOGUANINE
    WOLFF, SM
    GOODMAN, HC
    ARTHRITIS AND RHEUMATISM, 1963, 6 (03): : 306 - &